Nancy Thornberry

This profile gathers the share dealings of Nancy Thornberry across 3 companies, led by Denali Therapeutics Inc., Schrodinger, Inc. and Vertex Pharmaceuticals INC / MA. We count 16 filings; the first trade dates from 8 January 2022 and the latest from 2 September 2026.

Every open-market trade on record is a sale: 2 sales worth €226k. Other entries cover 12 share grants and 2 option exercises. Since January 2026: no purchases and 2 sales on the market.

On 4 September 2026 came the latest disclosure, an open-market sale for €13k in Denali Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.